Emergent BioSolutions Inc.EBSNYSE
Loading
Cash Flow PerformanceElevated
Percentile Rank100
5Y CAGR+23.2%
Studio
Year-over-Year Change

Free cash flow yield

5Y CAGR
+23.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202523.71%+235.6%
20247.07%+103.4%
2023-209.88%-728.4%
2022-25.33%-713.1%
20214.13%-50.6%
20208.37%+129.9%
20193.64%+456.7%
2018-1.02%-112.9%
20177.89%+557.2%
2016-1.73%-